Sai Life Sciences Limited (BOM:544306)

Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	219,604	158,581	-	-	-	-
Enterprise Value	220,717	166,413	-	-	-	-
Last Close Price	1036.90	762.10	-	-	-	-
PE Ratio	65.96	93.21	-	-	-	-
PS Ratio	10.12	9.36	-	-	-	-
PB Ratio	9.68	7.45	-	-	-	-
P/TBV Ratio	9.71	7.49	-	-	-	-
P/OCF Ratio	-	50.50	-	-	-	-
EV/Sales Ratio	10.17	9.82	-	-	-	-
EV/EBITDA Ratio	36.94	46.28	-	-	-	-
EV/EBIT Ratio	48.33	61.49	-	-	-	-
Debt / Equity Ratio	0.18	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.70	0.88	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Net Debt / Equity Ratio	0.05	-0.01	0.76	0.82	0.85	0.56
Net Debt / EBITDA Ratio	0.20	-0.05	3.03	5.77	8.19	3.59
Net Debt / FCF Ratio	-	0.36	9.13	6.85	-7.35	-1.62
Asset Turnover	-	0.62	0.66	0.56	0.44	-
Inventory Turnover	-	4.97	4.27	3.50	3.04	-
Quick Ratio	-	1.58	1.05	0.93	0.99	1.05
Current Ratio	-	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	-	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	-	6.22%	4.83%	1.90%	0.98%	-
Return on Invested Capital (ROIC)	14.33%	10.57%	7.83%	2.48%	1.34%	4.81%
Return on Capital Employed (ROCE)	-	11.10%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.52%	1.07%	-	-	-	-
FCF Yield	-	-0.35%	-	-	-	-
Buyback Yield / Dilution	-13.82%	-8.04%	-0.27%	-0.46%	-5.32%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.